Expenditures could rise nearly 8% this year, pressuring employers as healthcare costs eat up a larger share of their budgets, ...

Employees enrolled in HDHPs are often the most exposed to price volatility, making pharmacy strategy a critical lever in any cost-containment plan.

AG Liz Murrill explains why Louisiana filed three major lawsuits against CVS over controversial text messages and business ...

The high cost of prescription drugs in America has again moved back into the political spotlight, with President Trump ...

U.S. Senator Kirsten Gillibrand (D–N.Y.) is backing a bill that she contends would significantly reduce the cost of ...

Last year, the Federal Trade Commission called out pharmacy benefit managers — often described as prescription drug middlemen — for benefiting off of inflated drug prices. PBMs wield enormous ...

“It is time to restore the progress our Nation made in my first term to deliver lower prescription drug prices by putting Americans first and making America healthy again,” Trump wrote in the ...

President Donald Trump's new health care initiative aims to reduce prescription drug costs by targeting pharmacy benefit managers, commonly known as PBMs. Fox Business. Personal Finance.

Trump's Monday executive order instructing drug companies to reduce prices of prescription drugs or face federal government consequences amounts to price control since it’s not limited to just ...

It’s also unclear what power the administration has to get involved in other countries’ drug price negotiations with US pharmaceutical companies, though Trump warned that nations that don’t ...

President Donald Trump signed a sweeping executive order Monday morning that promises to crack down on “unreasonable or discriminatory” practices by foreign countries that result in Americans ...

Trump asks the drug industry to voluntarily lower prices for U.S. consumers or be subject to a barrage of regulatory ... U.S prescription drug prices run more than 2.5 times those in 32 ...